{"category": "ham", "to_address": "<aidsdrugs@lists.riseup.net>, \"ip-health\" <ip-health@lists.essential.org>,\n   \"thaifta lists\" <thaifta@lists.riseup.net>", "from_address": "\"Sean Flynn\" <sflynn@wcl.american.edu>", "subject": "[Ip-health] Thailand, Brazil and the need for CLs on second generation drugs", "body": "Mike and I prepared the enclosed poster with graphics displaying the\nneed for compulsory licenses and generic competition to achieve access\nto second generation AIDS drugs.\n\nIt applauds the licenses in Brazil and Thailand as a needed first step.\nAnd it provides an implicit warning against accepting new waves of price\ncuts by patent holding companies as a condition for refusing to issue\ncompulsory licenses: the scale of price reductions needed to treat the\nnearly 4 million people that will need access to second generation drugs\nover the next decade can only be accomplished with the kind of\ncompetitive provision of generic products in developing countries that\nwas achieved for the first generation of AIDS drugs.\n\nThis will be presented at the South African AIDS Conference on June 5\nand 6.\n\nhttp://www.wcl.american.edu/pijip/documents/2nd-generation-poster.pdf?rd\n=1\n\n_______________________________________________\nIp-health mailing list\nIp-health@lists.essential.org\nhttp://lists.essential.org/mailman/listinfo/ip-health\n\n"}